Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 601-606 of 606 matching filings.

Per page
25
Current page
25
6-K File 001-36421

FORM 6-K

Filing date
26 Jun 2014
Reporting date
23 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

FORM 6-K

Filing date
26 Jun 2014
Reporting date
26 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
40FR12B/A File 001-36421

40FR12B/A

Filing date
19 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-X File 001-36421

FORM F-X

Filing date
16 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
40FR12B File 001-36421

40FR12B

Filing date
16 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-212735

D filing

Filing date
28 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .